Jie Guo

发表

Design, synthesis and biological evaluation of coumarin-based N-hydroxycinnamamide derivatives as novel histone deacetylase inhibitors with anticancer activities.

Rikang Wang, Yi Jin, Jiaoli Ding, 2020, Bioorganic chemistry.

Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.

H. Abaan, Shaomeng Wang, Renxiao Wang, 2006, Journal of medicinal chemistry.

Structure-based design of flavonoid compounds as a new class of small-molecule inhibitors of the anti-apoptotic Bcl-2 proteins.

Shaomeng Wang, Renxiao Wang, Chao-yie Yang, 2007, Journal of medicinal chemistry.

Acylpyrogallols as inhibitors of antiapoptotic Bcl-2 proteins.

Shaomeng Wang, Chao-yie Yang, Z. Nikolovska-Coleska, 2008, Journal of medicinal chemistry.

Design, Synthesis and Anti‐Tumor Activity Evaluation of Novel 3,4‐(Methylenedioxy)cinnamic Acid Amide‐Dithiocarbamate Derivatives

Rikang Wang, Yi Jin, P. Liu, 2022, Chemistry & biodiversity.

Design, synthesis and biological evaluation of novel pyrazolone derivatives as selective butyrylcholinesterase inhibitors with antioxidant activity against Alzheimer's disease

Rikang Wang, Yi Jin, Jing Liu, 2022, Journal of Molecular Structure.

A multi-target directed ligands strategy for the treatment of Alzheimer's disease: Dimethyl fumarate plus Tranilast modified Dithiocarbate as AChE inhibitor and Nrf2 activator.

Yi Jin, P. Liu, Jing Liu, 2022, European journal of medicinal chemistry.

Single-stranded DNA-binding Protein in Vitro Eliminates the Orientation-dependent Impediment to Polymerase Passage on CAG/CTG Repeats*

C. McMurray, G. Goellner, Jie Guo, 2008, Journal of Biological Chemistry.

Design, synthesis, and biological evaluation of novel xanthone-alkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer's disease.

Rikang Wang, Yi Jin, Jing Liu, 2021, European journal of medicinal chemistry.

Design, Synthesis and Biological Evaluation of New 3,4-Dihydro-2(1H)-Quinolinone-Dithiocarbamate Derivatives as Multifunctional Agents for the Treatment of Alzheimer’s Disease

Rikang Wang, Yi Jin, Jing Liu, 2022, Drug design, development and therapy.

Novel AP2238-clorgiline hybrids as multi-target agents for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.

Jing Liu, Jie Guo, Yaqian Yan, 2022, Bioorganic chemistry.

MicroRNA-206 Inhibited the Progression of Glioblastoma Through BCL-2

Jian Li, Jie Guo, Maode Wang, 2016, Journal of Molecular Neuroscience.

Pyrogallol-based molecules as potent inhibitors of the antiapoptotic Bcl-2 proteins.

Sheng Jiang, Renxiao Wang, Su Qiu, 2007, Journal of medicinal chemistry.

Dual functional antioxidant and butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease: Design, synthesis and evaluation of novel melatonin-alkylbenzylamine hybrids.

Yi Jin, P. Liu, Jing Liu, 2022, Bioorganic & medicinal chemistry.

Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease.

Weizhong Tang, Jing Liu, Zhipeng Zhang, 2020, European journal of medicinal chemistry.

Acylpyrogallols as inhibitors of antiapoptotic Bcl-2 proteins.

Shaomeng Wang, Z. Nikolovska-Coleska, S. Qiu, 2008, Journal of medicinal chemistry.